MyAverix Finance
SA · Healthcare
Amgen Inc (AMGN34)
Drug Manufacturers - General
Amgen Inc (AMGN34) is listed on SA in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-29, reported market cap is $999.97B, P/E ratio is 24.91, net margin is 21.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for AMGN34
Amgen Inc (AMGN34) — FAQ
What is Amgen Inc's market cap?
Amgen Inc (AMGN34) has a reported market cap of $999.97B (data as of 2026-03-29).
What is AMGN34's P/E ratio?
The price-to-earnings (P/E) ratio for Amgen Inc (AMGN34) is 24.91 (data as of 2026-03-29).
Does Amgen Inc pay a dividend?
Dividend yield is not available in the current snapshot for Amgen Inc (AMGN34). Check the MyAverix Finance app for the latest dividend data.
What sector is Amgen Inc in?
Amgen Inc (AMGN34) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is AMGN34 listed on?
AMGN34 is listed on SA.
What is Amgen Inc's net margin?
Amgen Inc (AMGN34) reports a net margin of 21.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.